AU507828B2 - Quinazoline derivatives - Google Patents
Quinazoline derivativesInfo
- Publication number
- AU507828B2 AU507828B2 AU26687/77A AU2668777A AU507828B2 AU 507828 B2 AU507828 B2 AU 507828B2 AU 26687/77 A AU26687/77 A AU 26687/77A AU 2668777 A AU2668777 A AU 2668777A AU 507828 B2 AU507828 B2 AU 507828B2
- Authority
- AU
- Australia
- Prior art keywords
- quinazoline derivatives
- quinazoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70400176A | 1976-07-09 | 1976-07-09 | |
US70400276A | 1976-07-09 | 1976-07-09 | |
USUS704,002 | 1976-07-09 | ||
USUS704,001 | 1976-07-09 | ||
GBGB53,821/7 | 1976-12-23 | ||
GB5382176 | 1976-12-23 | ||
US78498777A | 1977-04-06 | 1977-04-06 | |
USUS784,987 | 1977-04-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2668777A AU2668777A (en) | 1979-01-04 |
AU507828B2 true AU507828B2 (en) | 1980-02-28 |
Family
ID=27449036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26687/77A Expired AU507828B2 (en) | 1976-07-09 | 1977-07-01 | Quinazoline derivatives |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS539796A (fi) |
AU (1) | AU507828B2 (fi) |
BE (1) | BE856647A (fi) |
CA (1) | CA1093555A (fi) |
CH (1) | CH634069A5 (fi) |
DE (1) | DE2731039A1 (fi) |
DK (1) | DK309977A (fi) |
FR (1) | FR2357563A1 (fi) |
IE (1) | IE45427B1 (fi) |
IN (1) | IN147488B (fi) |
MX (1) | MX5133E (fi) |
NL (1) | NL7707658A (fi) |
PH (1) | PH13539A (fi) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2095518A1 (en) * | 1990-11-14 | 1992-05-15 | Jeffrey M. Blaney | Specific inhibition of dihydrofolate reductase and compounds therefor |
KR100810468B1 (ko) * | 2001-10-10 | 2008-03-07 | 씨제이제일제당 (주) | 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난1h-인돌 유도체 |
US7262297B2 (en) * | 2003-05-15 | 2007-08-28 | Hoffmann-La Roche Inc. | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
US11077109B2 (en) * | 2017-08-01 | 2021-08-03 | The Trustees Of Princeton University | Compounds having antibacterial activity and methods of use |
-
1977
- 1977-06-29 IE IE1345/77A patent/IE45427B1/en unknown
- 1977-07-01 AU AU26687/77A patent/AU507828B2/en not_active Expired
- 1977-07-04 CA CA281,981A patent/CA1093555A/en not_active Expired
- 1977-07-07 PH PH19967A patent/PH13539A/en unknown
- 1977-07-08 DK DK309977A patent/DK309977A/da not_active Application Discontinuation
- 1977-07-08 MX MX775882U patent/MX5133E/es unknown
- 1977-07-08 DE DE19772731039 patent/DE2731039A1/de not_active Withdrawn
- 1977-07-08 FR FR7721232A patent/FR2357563A1/fr active Granted
- 1977-07-08 CH CH850677A patent/CH634069A5/de not_active IP Right Cessation
- 1977-07-08 NL NL7707658A patent/NL7707658A/xx not_active Application Discontinuation
- 1977-07-08 BE BE179213A patent/BE856647A/xx not_active IP Right Cessation
- 1977-07-09 JP JP8247077A patent/JPS539796A/ja active Granted
- 1977-11-15 IN IN1610/CAL/77A patent/IN147488B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA1093555A (en) | 1981-01-13 |
NL7707658A (nl) | 1978-01-11 |
BE856647A (fr) | 1978-01-09 |
JPS6254111B2 (fi) | 1987-11-13 |
JPS539796A (en) | 1978-01-28 |
PH13539A (en) | 1980-06-26 |
IE45427B1 (en) | 1982-08-25 |
IN147488B (fi) | 1980-03-15 |
IE45427L (en) | 1978-10-06 |
MX5133E (es) | 1983-03-28 |
FR2357563B1 (fi) | 1983-03-11 |
DE2731039A1 (de) | 1978-01-19 |
DK309977A (da) | 1978-01-10 |
AU2668777A (en) | 1979-01-04 |
CH634069A5 (en) | 1983-01-14 |
FR2357563A1 (fr) | 1978-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU509754B2 (en) | Benazepine derivatives | |
AU517585B2 (en) | Phenoxybenzyloxycarbonyl derivatives | |
AU507258B2 (en) | Fluoroacacylresorcin derivatives | |
AU506317B2 (en) | Quinazoline derivatives | |
AU506410B2 (en) | Quinazoline derivatives | |
AU504526B2 (en) | Pipeazine derivatives | |
AU517829B2 (en) | Morphanthridine derivatives | |
AU502122B2 (en) | 5-0-acylated-imidazole-4-carboxamide derivatives | |
AU515192B2 (en) | Quinoxaline-din-oxide derivatives | |
AU507828B2 (en) | Quinazoline derivatives | |
AU512647B2 (en) | Solpenamide derivatives | |
ZA772728B (en) | Quinazoline derivatives | |
AU4157678A (en) | Quinazoline derivatives | |
AU507708B2 (en) | Hydrazino-pyridazine derivatives | |
AU513069B2 (en) | 17-spirosiltine derivatives | |
AU514803B2 (en) | 4-phenylpipridine derivatives | |
AU505150B2 (en) | Triazolobenzazepine derivatives | |
JPS5289682A (en) | Quinazoline derivatives | |
AU519085B2 (en) | 1-carba-2-penem derivatives | |
AU503490B2 (en) | Aminoalkyl-dibenzocyclohepton-5-one derivatives | |
AU511948B2 (en) | Nortropine-carbazate derivatives | |
AU1858676A (en) | Aminoalkyl-dibenzocyclohepton-5-one derivatives | |
AU495377B2 (en) | 3-nitropyrazole derivatives | |
AU515135B2 (en) | Ribofuranosyl-imidazole derivatives | |
AU508555B2 (en) | 6-carboxy-flavone derivatives |